NOVARTIS TESTED SWINE FLU VACCINE ON PEOPLE IN POLAND WITHOUT AUTHORISATION

NOVARTIS TESTED SWINE FLU VACCINE ON PEOPLE IN POLAND WITHOUT AUTHORISATION

Thursday, 07 January 2010 11:40



The Swiss pharmaceutical company Novartis appears to have tested the swine flu jab with squalene on people in Poland without authorisation and without informing the participating doctors, hospitals and clinics about the content of the vaccine material, according to a report on Polskaweb.

http://polskaweb.eu/illegale-ahn1n1-impfstoff-tests-in-polen-7367356752562.html



Novartis tested its swine flu vaccine "Focetria" on Polish people without informing them or the doctors who administered it about its name or origin, investigative journalists from Poland's TVN found out.

The Polish health ministry has issued a statement saying that no authorisation for clinical trials involving the swine flu vaccine was given to Novartis, although trials for bird flu vaccines were authorised last September.

"Neither the Health Ministry nor the Registration Office For Drugs and Medicines have given any pharmaceutical company permission for clinical studies using a vaccine against the "swine flu" H1N! in Poland," the health ministry said in a press release.

Novartis has refused to confirm whether they received authorisation or not. The Novartis subsidiary in Warsaw has directed inquiries to the company headquarters in Switzerland.

The EMEA, the European drug regulator, website indicates Novartis has tested its Focetria drug.

"We have tested the vaccine until now on 661 "health adults of all age groups. A similar study has also been carried out with 720 health children and young people from 6 months to 17 years of age," material says.

Novartis has refused to comment on where these tests were carried out, but 1381 Polish children and adults could have been involved in these tests in Poland.

However, Polskaweb points out that Novartis may never conducted tests on the swine flu vaccine at all and have tested something else in Poland.